Insufficient S-adenosylhomocysteine hydrolase compromises the beneficial effect of diabetic BMSCs on diabetic cardiomyopathy.
Stem Cell Res Ther
; 13(1): 418, 2022 08 13.
Article
in En
| MEDLINE
| ID: mdl-35964109
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Experimental
/
Diabetic Cardiomyopathies
/
Mesenchymal Stem Cells
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Stem Cell Res Ther
Year:
2022
Document type:
Article
Country of publication:
United kingdom